Anti-TTF-1 antibodies are commonly used in routine pathology diagnostics, assisting in the differential diagnosis between squamous cell carcinomas and adenocarcinomas of the lung (which usually show TTF-1 positivity). This evidence concerns the gene TTF1 and lung adenocarcinoma.